COMBINATION THERAPY
Clinical trials for COMBINATION THERAPY explained in plain language.
Never miss a new study
Get alerted when new COMBINATION THERAPY trials appear
Sign up with your email to follow new studies for COMBINATION THERAPY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New antibody combo targets tough lymphoma in early trial
Disease control Not yet recruitingThis study tests a new drug called EMB-07, a bispecific antibody that helps the immune system attack cancer cells. It is for adults with aggressive B-cell non-Hodgkin lymphoma, either newly diagnosed or that has returned after treatment. The trial will check safety, side effects,…
Matched conditions: COMBINATION THERAPY
Phase: PHASE1, PHASE2 • Sponsor: Shanghai EpimAb Biotherapeutics Co., Ltd. • Aim: Disease control
Last updated May 11, 2026 20:50 UTC
-
New combo treatment aims to tame chronic migraines
Symptom relief Not yet recruitingThis study tests whether combining Botox injections with a nerve block can better ease chronic migraines than either treatment alone. About 90 adults with frequent migraines will receive one or both treatments. The goal is to reduce headache days and improve daily life.
Matched conditions: COMBINATION THERAPY
Phase: NA • Sponsor: Beni-Suef University • Aim: Symptom relief
Last updated May 11, 2026 20:37 UTC